276 resultados para Topi Salmi -palkinto
Resumo:
back row L-R: Michael Bass, Rick Volk, Frank Nunley, Dennis Morgan, Rick Sygar, John Rowser. front row L-R: terry Salmi, Kenneth Wright, David Porter, Richard Williamson, Roger Rosema.
Resumo:
fasc.I., I.Annonymi chiliastae in Matthaeum XXIV fragmenta. Accedunt tractus De tribus mensuris et De Petro apostolo.-II. Piccoli supplementi agliscritti dei dottori Cappadoci e di S. Cirillo Alessandrino.-III. I fragmenti inediti dell'antica versione latina del commentario di Teodoro Mopsuesteno sui Salmi.
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
Added t.p. has title also in German.
Resumo:
Title from cover
Reformulation of a thermostable broadly protective recombinant vaccine against human papilloma virus
Resumo:
The causal relationship between Human Papilloma Virus (HPV) infection and cervical cancer has motivated the development, and further improvement, of prophylactic vaccines against this virus. 70% of cervical cancers, 80% of which in low-resources countries, are associated to HPV16 and HPV18 infection, with 13 additional HPV types, classified as high-risk, responsible for the remaining 30% of tumors. Current vaccines, Cervarix® (GlaxoSmithKline) and Gardasil®(Merk), are based on virus-like particles (VLP) obtained by self-assembly of the major capsid protein L1. Despite their undisputable immunogenicity and safety, the fact that protection afforded by these vaccines is largely limited to the cognate serotypes included in the vaccine (HPV 16 and 18, plus five additional viral types incorporated into a newly licensed nonavalent vaccine) along with high production costs and reduced thermal stability, are pushing the development of 2nd generation HPV vaccines based on minor capsid protein L2. The increase in protection broadness afforded by the use of L2 cross-neutralizing epitopes, plus a marked reduction of production costs due to bacterial expression of the antigens and a considerable increase in thermal stability could strongly enhance vaccine distribution and usage in low-resource countries. Previous studies from our group identified three tandem repeats of the L2 aa. 20-38 peptide as a strongly immunogenic epitope if exposed on the scaffold protein thioredoxin (Trx). The aim of this thesis work is the improvement of the Trx-L2 vaccine formulation with regard to cross-protection and thermostability, in order to identify an antigen suitable for a phase I clinical trial. By testing Trx from different microorganisms, we selected P. furiosus thioredoxin (PfTrx) as the optimal scaffold because of its sustained peptide epitope constraining capacity and striking thermal stability (24 hours at 100°C). Alternative production systems, such as secretory Trx-L2 expression in the yeast P. pastoris, have also been set-up and evaluated as possible means to further increase production yields, with a concomitant reduction of production costs. Limitations in immune-responsiveness caused by MHC class II polymorphisms –as observed, for example, in different mouse strains- have been overcome by introducing promiscuous T-helper (Th) epitopes, e.g., PADRE (Pan DR Epitope), at both ends of PfTrx. This allowed us to obtain fairly strong immune responses even in mice (C57BL/6) normally unresponsive to the basic Trx-L2 vaccine. Cross-protection was not increased, however. I thus designed, produced and tested a novel multi-epitope formulation consisting of 8 and 11 L2(20-38) epitopes derived from different HPV types, tandemly joined into a single thioredoxin molecule (“concatemers”). To try to further increase immunogenicity, I also fused our 8X and 11X PfTrx-L2 concatemers to the N-terminus of an engineered complement-binding protein (C4bp), capable to spontaneously assemble into ordered hepatmeric structures, previously validated as a molecular adjuvant. Fusion to C4bp indeed improved antigen presentation, with a fairly significant increase in both immunogenicity and cross-protection. Another important issue I addressed, is the reduction of vaccine doses/treatment, which can be achieved by increasing immunogenicity, while also allowing for a delayed release of the antigen. I obtained preliminary, yet quite encouraging results in this direction with the use of a novel, solid-phase vaccine formulation, consisting of the basic PfTrx-L2 vaccine and its C4bp fusion derivative adsorbed to mesoporus silica-rods (MSR).
Resumo:
We investigate the effects of organizational culture and personal values on performance under individual and team contest incentives. We develop a model of regard for others and in-group favoritism that predicts interaction effects between organizational values and personal values in contest games. These predictions are tested in a computerized lab experiment with exogenous control of both organizational values and incentives. In line with our theoretical model we find that prosocial (proself) orientated subjects exert more (less) effort in team contests in the primed prosocial organizational values condition, relative to the neutrally primed baseline condition. Further, when the prosocial organizational values are combined with individual contest incentives, prosocial subjects no longer outperform their proself counterparts. These findings provide a first, affirmative, causal test of person-organization fit theory. They also suggest the importance of a 'triple-fit' between personal preferences, organizational values and incentive mechanisms for prosocially orientated individuals.
Resumo:
Gli esperimenti condotti in questo progetto di ricerca sono volti allo studio degli effetti di integratori a base di clorofillina magnesiaca sullo stato di stress ossidativo sui tessuti murini. Per le analisi sono state prese in esame due corti di topi femmine da 48 e 44 esemplari ciascuna. Le due corti sono state sottoposte a un diverso tipo di trattamento, rispettivamente: trattamento cronico con diverse quantità di soluzione idroalcolica di clorofillina magnesiaca e trattamento acuto con unica dose standard di soluzione idroalcolica di clorofillina magnesiaca. In questo modo è stato possibile studiare l'efficacia degli integratori in base al tipo di trattamento. Le analisi sono state fatte con saggio TBARS sui topi della prima corte e con saggio FRAP sui topi di entrambe le corti. Il saggio TBARS mostra lo stato di tress ossidativo dei tessuti mediante quantificazione della malondialdeide. Il saggio FRAP descrive la capacità riducente della clorofilliana estratta dai campioni di tessuto. In un progetto parallelo a quello descritto in questa tesi è stata quantificata la clorofilla tramite spettrofluorimetria per costruire un parallelo fra quantità e potere riducente rilevato. Grazie all'analisi dei risultati è possibile dire che la clorofillina magnesiaca non è proossidante e presenta potere riducente. Tuttavia un trattamento acuto non è sufficiente a farla accumulare nei tessuti.
Resumo:
L’epcidina (HAMP) è un ormone peptidico coinvolto nella regolazione sistemica dell’omeostasi del ferro e risulta essere espresso anche a livello cardiaco. Questo studio è stato condotto per approfondire le conoscenze riguardo al ruolo dell’epcidina e dei geni regolatori del ferro e il loro coinvolgimento nella patologie cardiache. Sono stati condotti studi sull’atassia di Friedreich (FRDA), una patologia neurodegenerativa caratterizzata dallo sviluppo di una cardiomiopatia da sovraccarico di ferro. A tale scopo, sono stati derivati cardiomiociti da cellule staminali pluripotenti indotte umane (hiPSCs) di un paziente affetto da FRDA e da un soggetto sano (Ctr) e in queste cellule è stata analizzata l’espressione del gene HAMP. I risultati ottenuti hanno evidenziato un aumento significativo dell’espressione genica di HAMP nei cardiomiociti FRDA rispetto ai controlli. Parallelamente, l’espressione genica di HAMP e di altri geni regolatori del ferro è stata analizzata in un modello animale murino sottoposto a ipossia intermittente (IH) e a un danno ischemico indotto dalla legatura coronarica (LAD). Nel gruppo di topi normossici sottoposti alla legatura coronarica (Normo LAD) è stata evidenziato un aumento dell’espressione genica di HAMP simile a quello riscontrato nei cardiomiociti FRDA, suggerendo che questo gene potrebbe essere indotto in presenza di un danno cardiaco. Inoltre, l’espressione della ferritina, una proteina coinvolta nello storage del ferro con attività antiossidante, rimane invariata nei topi sottoposti a un danno cardiaco come la LAD, mentre risulta essere aumentata nei topi sottoposti a IH. Pertanto, l’aumento di espressione della ferritina potrebbe contribuire ai meccanismi di cardioprotezione indotti dall’ipossia intermittente. I risultati di espressione genica ottenuti in questo studio saranno validati mediante studi di espressione proteica.
Resumo:
Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.
Resumo:
We experimentally subliminally prime subjects prior to charity donation decisions by showing words that have connotations of pro-social values for a very brief time (17ms). Our main fnding is that, compared to a baseline condition, the pro-social prime increases donations by approximately 10-17 percent among subjects with strong pro-social preferences (universalism values). We find a similar effect when interacting the prime with the Big 5 personality characteristic of agreeableness. We furthermore introduce a novel method for testing for priming, "subliminity". This method reveals that some subjects are capable of recognizing prime words, and the overall results are weaker when we control for this capacity.
Resumo:
Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.